I-Brexpiprazole CAS 913611-97-9 Purity >99.0% (HPLC) Isithombe Esifakiwe Sefektri ye-API

I-Brexpiprazole CAS 913611-97-9 Purity >99.0% (HPLC) API Factory

Incazelo emfushane:

Igama Lekhemikhali: Brexpiprazole

I-CAS: 913611-97-9

Ubumsulwa: >99.0% (HPLC)

Ukubukeka: I-Crystalline Powder Emhlophe noma Engamhlophe

Ikhwalithi ephezulu ye-API, Ukukhiqiza Kwezentengiso

E-Mail: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

I-Ruifu Chemical Supply Brexpiprazole Intermediates
I-Brexpiprazole CAS 913611-97-9
I-7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-one CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3

Chemical Properties:

Igama Lekhemikhali	I-Brexpiprazole
Omqondofana	I-OPC-34712;7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one
Inombolo ye-CAS	913611-97-9
Inombolo yeCAT	I-RF-PI1982
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C25H27N3O2S
Isisindo samangqamuzana	433.57
Ukuminyana	1.245±0.060 g/cm3
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	I-Crystalline Powder Emhlophe noma Engamhlophe
Ukuhlonza	Ibhalwe ngu-IR
RT	Ngaphansi kwe-chirality kufanele ihambisane
I-Chloride	Inikeza ukusabela kwe-chloride
Amanzi	3.0%~4.5%
I-Melting Point	198.0~202.0℃
Izinsalela ekushiseni	<0.20%
Izinsimbi Ezisindayo	≤10ppm
Izinto Ezihlobene
Ukungcola Ngamunye	<0.50%
Ukungcola Okuphelele	<1.00%
EE	>99.0%
Ukuhlanzeka / Indlela Yokuhlaziya	>99.0% (HPLC, ngokomile)
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	I-API

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

I-FAQ:

Isicelo:

I-Brexpiprazole (CAS: 913611-97-9) iyikhandidethi lezidakamizwa eliwusizo ekwelapheni nasekuvimbeleni ukuphazamiseka kwengqondo okuhlanganisa ukuphazamiseka kwe-CNS.I-Brexpiprazole iyinoveli yesidakamizwa se-antipsychotic esebenza njengemoduli yomsebenzi we-serotonin ® dopamine futhi ibonise ukusebenza kahle njengokwelashwa okungeziwe ezigulini ezinokuphazamiseka okukhulu kokucindezeleka (MDD).I-Brexpiprazole ibonisa iphrofayili ye-pharmacological eyingqayizivele, esebenza njenge-agonist ingxenye ye-serotonin 5-HT1A kanye ne-dopamine D2 receptors futhi njengomphikisi ogcwele we-5-HT2A kanye ne-noradrenaline α1B / 2C receptors, enobudlelwane obubophezelayo obufanayo be-subnanomolar.I-Brexpiprazole yathuthukiswa ngabakwa-Otsuka kanye no-Lundbeck, yagunyazwa ngo-2015 yi-FDA yokwelapha i-schizophrenia kanye nokwelapha okuhlanganisa nokudangala.I-Brexpiprazole ibhekwa kabanzi njengelandela isidakamizwa se-antipsychotic sika-Otsuka i-aripiprazole (igama lokuhweba i-Abilify) ilungelo layo lobunikazi eliphelelwe yisikhathi ngo-Agasti 2014.